SCPX 0.84 Scorpius Holdings, Inc.
| Range: | 0.02-8.11 | Vol Avg: | 122185 | Last Div: | 0 | Changes: | 0.05 |
| Beta: | -0.31 | Cap: | 0.00B | Currency: | USD | Exchange: | AMEX |
| Sector: | Healthcare | IPO: | Wed Jul 24 2013 | Empoloyees: | 82 | ||
| CUSIP: | CIK: | 0001476963 | ISIN: | US42237K4094 | Country: | US | |
| CEO: | Mr. Jeffrey Alan Wolf J.D. | Website: | https://www.scorpiusbiologics.com | ||||
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow